Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines

Phase 1 and 2 clinical trials of group B streptococcal (GBS) capsular polysaccharide (CPS)-protein conjugate vaccines in healthy adults have demonstrated their safety and improved immunogenicity compared with uncoupled CPSs. Two recent trials sought to determine (i) whether adsorption of conjugate v...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Paoletti, L. C., Rench, M. A., Kasper, D. L., Molrine, D., Ambrosino, D., Baker, C. J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Microbial Immunity and Vaccines
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC100045/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11598040/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.69.11.6696-6701.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!